Times Square Capital Management, LLC Repligen Corp Transaction History

Times Square Capital Management, LLC

  • $6.24 Billion
  • Q3 2025

A detailed history of Times Square Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Times Square Capital Management, LLC holds 362,129 shares of RGEN stock, worth $55.2 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
362,129
Previous 240,231 50.74%
Holding current value
$55.2 Million
Previous $29.9 Million 62.0%
% of portfolio
0.78%
Previous 0.46%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$111.43 - $134.0 $13.6 Million - $16.3 Million
121,898 Added 50.74%
362,129 $48.4 Million
Q2 2025

Aug 08, 2025
BUY
$108.89 - $145.23 $462,129 - $616,356
4,244 Added 1.8%
240,231 $29.9 Million
Q1 2025

May 02, 2025
SELL
$127.24 - $174.24 $3.18 Million - $4.36 Million
-25,005 Reduced 9.58%
235,987 $30 Million
Q4 2024

Feb 03, 2025
SELL
$123.41 - $160.92 $1.81 Million - $2.36 Million
-14,635 Reduced 5.31%
260,992 $37.6 Million
Q3 2024

Nov 04, 2024
BUY
$119.79 - $167.35 $4.21 Million - $5.88 Million
35,115 Added 14.6%
275,627 $41 Million
Q2 2024

Aug 08, 2024
BUY
$120.0 - $182.95 $5.57 Million - $8.5 Million
46,439 Added 23.93%
240,512 $30.3 Million
Q1 2024

May 07, 2024
SELL
$170.78 - $208.42 $2.02 Million - $2.46 Million
-11,810 Reduced 5.74%
194,073 $35.7 Million
Q4 2023

Feb 07, 2024
BUY
$114.17 - $185.35 $8.97 Million - $14.6 Million
78,591 Added 61.74%
205,883 $37 Million
Q3 2023

Nov 17, 2023
SELL
$138.78 - $176.51 $14.2 Million - $18.1 Million
-102,636 Reduced 44.64%
127,292 $20.2 Million
Q2 2023

Aug 09, 2023
BUY
$138.42 - $180.31 $7.92 Million - $10.3 Million
57,233 Added 33.14%
229,928 $32.5 Million
Q1 2023

May 10, 2023
BUY
$154.26 - $198.1 $26.6 Million - $34.2 Million
172,695 New
172,695 $29.1 Million
Q4 2018

Feb 14, 2019
SELL
$48.26 - $68.88 $38.8 Million - $55.4 Million
-803,991 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$46.8 - $58.97 $59.6 Million - $75 Million
-1,272,515 Reduced 61.28%
803,991 $0
Q2 2018

Aug 14, 2018
SELL
$35.26 - $47.04 $8.61 Million - $11.5 Million
-244,127 Reduced 10.52%
2,076,506 $97.7 Million
Q1 2018

May 15, 2018
SELL
$30.92 - $37.27 $5.89 Million - $7.1 Million
-190,487 Reduced 7.59%
2,320,633 $84 Million
Q4 2017

Feb 14, 2018
BUY
$32.53 - $38.92 $6.41 Million - $7.66 Million
196,900 Added 8.51%
2,511,120 $91.1 Million
Q3 2017

Nov 09, 2017
SELL
$36.98 - $46.06 $1.74 Million - $2.17 Million
-47,050 Reduced 1.99%
2,314,220 $88.7 Million
Q2 2017

Aug 10, 2017
BUY
N/A
2,361,270
2,361,270 $97.9 Million

Others Institutions Holding RGEN

# of Institutions
523
Shares Held
58.8M
Call Options Held
323K
Put Options Held
667K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email